PCNA staining by immunohistochemistry showed a higher proliferative rate in tumors co-injected with CSC-EV-stimulated MSCs (4.7 fold increase) than in tumor containing unstimulated MSCs (Fig. 6E, 6F, 6G, and 6H). Here, PCNA is linked to neoplasm.